Genscript Biotech (GNNSF) Short Interest Ratio & Short Volume C$2.20 0.00 (0.00%) As of 06/20/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Genscript Biotech Short Interest DataGenscript Biotech (GNNSF) has a short interest of 7.37 million shares. This marks a 0.24% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 3,625 shares to cover all short positions.Current Short Interest7,366,400 sharesPrevious Short Interest7,349,000 sharesChange Vs. Previous Month+0.24%Dollar Volume Sold Short$9.98 millionShort Interest Ratio0.0 Days to CoverLast Record DateMay 31, 2025Today's Trading Volume0 sharesAverage Trading Volume3,625 sharesToday's Volume Vs. Average0% Short Selling Genscript Biotech? Sign up to receive the latest short interest report for Genscript Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNNSF Short Interest Over TimeGNNSF Days to Cover Over TimeGNNSF Percentage of Float Shorted Over Time Genscript Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20257,366,400 shares C$9.98 million +0.2%N/A0 $1.36 5/15/20257,349,000 shares C$9.96 million -1.4%N/A36745 $1.36 4/30/20257,450,600 shares C$9.69 million -1.4%N/A0 $1.30 4/15/20257,558,600 shares C$9.83 million +131.4%N/A2042.9 $1.30 3/31/20253,266,600 shares C$4.90 million +832.3%N/A10888.7 $1.50 3/15/2025350,400 shares C$504.58 thousand -10.3%N/A438 $1.44 2/28/2025390,400 shares C$741.76 thousand -29.0%N/A300.3 $1.90 2/15/2025549,600 shares C$681.50 thousand -70.6%N/A2748 $1.24 1/31/20251,867,800 shares C$2.53 million -40.1%N/A217.2 $1.36 1/15/20253,117,800 shares C$3.96 million -36.9%N/A44.7 $1.27 Get the Latest News and Ratings for GNNSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genscript Biotech and its competitors with MarketBeat's FREE daily newsletter. 12/31/20244,938,600 shares C$6.27 million +3.5%N/A7055.1 $1.27 12/15/20244,770,600 shares C$5.96 million -0.7%N/A1325.2 $1.25 11/30/20244,802,600 shares C$6.58 million -13.7%N/A1778.7 $1.37 11/15/20245,562,800 shares C$7.73 million +2.5%N/A13907 $1.39 10/31/20245,426,400 shares C$8.33 million -3.5%N/A2359.3 $1.54 10/15/20245,624,400 shares C$7.87 million -11.9%N/A14061 $1.40 9/30/20246,386,400 shares C$8.94 million -6.0%N/A3548 $1.40 9/15/20246,791,800 shares C$9.58 million +1.2%N/A16979.5 $1.41 8/31/20246,713,800 shares C$10.22 million -1.5%N/A16784.5 $1.52 8/15/20246,817,800 shares C$10.94 million +4.6%N/A114 $1.61 7/31/20246,519,800 shares C$10.46 million +16.7%N/A65198 $1.61 7/15/20245,588,000 shares C$8.94 million +6.4%N/A46.5 $1.60 6/30/20245,253,800 shares C$5.52 million +1.9%N/A0 $1.05 6/15/20245,158,200 shares C$5.42 million -21.3%N/A1394.1 $1.05 5/31/20246,557,600 shares C$9.18 million -5.7%N/A42.4 $1.40 5/15/20246,955,800 shares C$10.23 million -34.8%N/A69.3 $1.47 4/30/202410,662,000 shares C$16.10 million +118.8%N/A1239.8 $1.51 4/15/20244,873,900 shares C$9.75 million +288.1%N/A955.7 $2.00 3/31/20241,255,900 shares C$2.51 million -17.9%N/A138 $2.00 3/15/20241,530,000 shares C$3.14 million -26.3%N/A2550 $2.05 2/29/20242,076,000 shares C$4.14 million -31.1%N/A1596.9 $1.99 2/15/20243,014,000 shares C$5.27 million -16.2%N/A418.6 $1.75 1/15/20243,594,000 shares C$8.77 million -7.6%N/A73.3 $2.44 12/31/20233,888,000 shares C$9.49 million -5.8%N/A9994.9 $2.44 12/15/20234,125,000 shares C$13.20 million -6.6%N/A165.7 $3.20 11/30/20234,414,100 shares C$14.12 million +0.9%N/A44141 $3.20 11/15/20234,376,100 shares C$12.45 million -7.4%N/A71.7 $2.85 10/31/20234,726,000 shares C$12.46 million -4.4%N/A381.1 $2.64 10/15/20234,942,000 shares C$13.03 million +7.5%N/A0 $2.64 9/30/20234,596,000 shares C$12.12 million +2.6%N/A15320 $2.643..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 9/15/20234,478,000 shares C$10.84 million -5.7%N/A99.1 $2.42 8/31/20234,748,000 shares C$10.26 million -13.9%N/A43963 $2.16 8/15/20235,515,500 shares C$11.91 million -27.6%N/A79.4 $2.16 7/31/20237,621,500 shares C$16.46 million +2.9%N/A82.2 $2.16 7/15/20237,405,600 shares C$15.92 million -5.3%N/A74056 $2.15 6/30/20237,816,500 shares C$17.63 million +1.1%N/A186.1 $2.26 6/15/20237,734,500 shares C$18.18 million +6.2%N/A332 $2.35 5/31/20237,286,500 shares C$18.94 million +7.7%N/A36432.5 $2.60 5/15/20236,764,500 shares C$17.32 million +22.5%N/A67645 $2.56 4/30/20235,524,500 shares C$14.14 million +31.8%N/A1905 $2.56 4/15/20234,192,500 shares C$10.44 million +73.7%N/A41925 $2.49 3/31/20232,413,500 shares C$5.62 million +64.5%N/A8045 $2.33 3/15/20231,467,000 shares C$3.68 million +20.9%N/A3667.5 $2.51 2/28/20231,213,000 shares C$3.44 million +16.3%N/A3032.5 $2.84 2/15/20231,043,000 shares C$3.02 million +109.9%N/A2607.5 $2.90 1/31/2023497,000 shares C$1.69 million +16.9%N/A828.3 $3.41 1/15/2023425,000 shares C$1.46 million -8.2%N/A386.4 $3.44 12/30/2022463,000 shares C$1.37 million -3.3%N/A2315 $2.96 12/15/2022479,000 shares C$1.44 million -5.6%N/A2395 $3.00 11/30/2022507,200 shares C$1.21 million -10.4%N/A11.9 $2.38 11/15/2022566,000 shares C$1.63 million -20.6%N/A2830 $2.88 10/31/2022713,000 shares C$1.80 million +0.3%N/A68.6 $2.53 10/15/2022711,200 shares C$1.34 million +0.5%N/A52.3 $1.89 9/30/2022708,000 shares C$1.64 million +43.2%N/A643.6 $2.32 9/15/2022494,300 shares C$1.27 million +2.1%N/A329.5 $2.57 8/31/2022484,000 shares C$1.69 million +14.7%N/A4840 $3.49 8/15/2022422,000 shares C$1.58 million -26.0%N/A844 $3.75 7/31/2022570,000 shares C$2.22 million -8.4%N/A0 $3.90 7/15/2022622,000 shares C$2.43 million -21.7%N/A100.3 $3.90 6/30/2022794,300 shares C$2.79 million +16.5%N/A1323.8 $3.51 6/15/2022682,000 shares C$2.36 million -17.6%N/A2273.3 $3.47 5/31/2022828,000 shares C$2.17 million +42.8%N/A360 $2.62 5/15/2022580,000 shares C$1.38 million +80.1%N/A161.1 $2.38 4/30/2022322,000 shares C$904.82 thousand 0.0%N/A536.7 $2.81 4/15/2022322,100 shares C$985.30 thousand -11.5%N/A51.1 $3.06 3/31/2022364,100 shares C$1.27 million -60.5%N/A82.8 $3.49 3/15/2022922,500 shares C$2.32 million +2.4%N/A80.2 $2.52 2/28/2022900,500 shares C$3.43 million -34.0%N/A450.3 $3.81 2/15/20221,364,100 shares C$4.80 million -6.6%N/A593.1 $3.52 1/31/20221,460,500 shares C$4.49 million +73.6%N/A1622.8 $3.08 1/15/2022841,400 shares C$3.57 million +118.9%N/A1682.8 $4.24 12/31/2021384,300 shares C$0.00 -22.5%N/A3843 $0.00 GNNSF Short Interest - Frequently Asked Questions What is Genscript Biotech's current short interest? Short interest is the volume of Genscript Biotech shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 7,366,400 shares of GNNSF short. Learn More on Genscript Biotech's current short interest. Is Genscript Biotech's short interest increasing or decreasing? Genscript Biotech saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 7,366,400 shares, an increase of 0.2% from the previous total of 7,349,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Genscript Biotech stock? Short selling GNNSF is an investing strategy that aims to generate trading profit from Genscript Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genscript Biotech? A short squeeze for Genscript Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNNSF, which in turn drives the price of the stock up even further. How often is Genscript Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNNSF, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies TRSBF Short Interest AGNPF Short Interest AKBLF Short Interest APLMW Short Interest ASPHF Short Interest ASCLF Short Interest AVCTF Short Interest AWKNF Short Interest AXIM Short Interest BCTXW Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GNNSF) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genscript Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genscript Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GNNSF Stock Free GNNSF Stock Alerts